FIELD: pharmacology.
SUBSTANCE: invention is an intranasal means for influenza prevention containing oxidized dextran with a molecular weight of 40-70 kDa, sodium benzoate, potassium sorbate and a pharmaceutically acceptable solvent, the components in the agent being in a certain ratio %.
EFFECT: increased means stability.
2 cl, 1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION FOR INFLUENZA PREVENTION | 2014 |
|
RU2572332C1 |
| MEANS FOR PREVENTION OF INTERSTITIAL PNEUMONIA | 2020 |
|
RU2747550C1 |
| MEANS AND METHOD FOR PREVENTION OF INTERSTITIAL PNEUMONIA OF INFECTIOUS ETIOLOGY | 2021 |
|
RU2784177C1 |
| SPRAY FOR ORAL APPLICATION, CONTAINING CHOLINE ALFOSCERATE | 2015 |
|
RU2632718C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING TICK-BORNE ENCEPHALITIS | 2012 |
|
RU2472504C1 |
| NEW FORMULATIONS OF 2-(IMIDAZOLE-4-YL)-ETHANAMIDE PENTANEDIOIC-1,5 ACID FOR THE TREATMENT AND PREVENTION OF VIRAL DISEASES | 2020 |
|
RU2782532C2 |
| NOVEL FORMULATIONS OF 2-(IMIDAZOL-4-YL)-ETHANAMIDE OF PENTANEDIOIC ACID FOR TREATMENT AND PREVENTION OF VIRAL DISEASES | 2020 |
|
RU2791902C2 |
| NOVEL 2-(IMIDAZOL-4-YL)-ETHANAMIDE OF PENTANDIOIC-1,5 ACID COMPOSITIONS FOR TREATING AND PREVENTING VIRAL DISEASES | 2019 |
|
RU2745265C2 |
| SPRAY FOR ORAL APPLICATION CONTAINING CHOLINE ALPHOCERATE | 2017 |
|
RU2684118C2 |
| THERAPEUTIC AND PROPHYLACTIC TOOTHPASTE | 2011 |
|
RU2462231C1 |
